Rev. Bras. Hematol. Hemoter. vol.33 número6

Jesús M Hernández-Rivas Secondary myeloid neoplasias are a heterogeneous group of diseases characterized by the proliferation of myeloid cells; they were recently recognized by

They evaluated the efficacy and safety of IV iron sucrose (IS, 200 mg/week, until anemia correction or replenishment of calculated ID; 515 infusions) for the treatment of 86

The secretor gene that encodes for 2-alpha-L-fucosyltransferase and the ABO blood grouping system that encodes for glycosyltransferases, act in concert to build-up

Better information for better health care: the Evidence-based Practice Center program and the Agency for Healthcare Research and Quality?. Ann

Stimulation using granulocyte growth factors associated or not to chemotherapy, is broadly used as a method in the mobilization of hematopoietic progenitor cells (HPC) from bone

The myelodysplastic syndromes (MDS), acute myeloid leukemias (AML) and secondary myeloproliferative syndromes (MPS) constitute a group of myeloid neoplasias (MNs) which result

Rev Bras

Are the review criteria for automated complete blood counts of the International Society of Laboratory Hematology suitable for all hematology laboratories.. Rev Bras